Dynavax Technologies
DVAX
#5493
Rank
NZ$2.22 B
Marketcap
NZ$18.98
Share price
-0.09%
Change (1 day)
-13.77%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.92 Billion

According to Dynavax Technologies 's latest financial reports the company has NZ$0.92 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$1.05 B7.58%
2023-12-31$NZ$0.98 B7.49%
2022-12-31$NZ$0.91 B181.09%
2021-12-31$NZ$0.32 B300.23%
2020-12-31$NZ$81.34 M560.84%
2019-12-31$NZ$12.3 M-86.91%
2018-12-31$NZ$94.01 M-66.54%
2017-12-31$NZ$0.28 B118.19%
2016-12-31$NZ$0.12 B-52.89%
2015-12-31$NZ$0.27 B113.14%
2014-12-31$NZ$0.12 B-43.43%
2013-12-31$NZ$0.22 B62.41%
2012-12-31$NZ$0.13 B9.07%
2011-12-31$NZ$0.12 B89.46%
2010-12-31$NZ$67.54 M669.45%
2009-12-31$NZ$8.77 M-68.47%
2008-12-31$NZ$27.84 M-45.5%
2007-12-31$NZ$51.08 M-54.48%
2006-12-31$NZ$0.11 B3.16%
2005-12-31$NZ$0.10 B29.66%
2004-12-31$NZ$83.91 M-195.36%
2003-12-31$-NZ$88 Million-18.31%
2002-12-31$-NZ$0.11 Billion29.96%
2001-12-31$-NZ$82.89 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-NZ$0.49 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$31.52 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.87 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$37.14 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$79.59 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
NZ$36.66 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$161.18 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$12.55 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$16.65 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA